WallStreetZenWallStreetZen

NASDAQ: AVTX
Avalo Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Avalo Therapeutics earnings were -$36.2M for the trailing 12 months ending Jun 30, 2024, with N/A growth year over year. The latest AVTX earnings report on Jun 30, 2024 announced Q2 2024 earnings of $98.5M, down 181.2% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, AVTX reported annual earnings of -$31.5M, with -24.3% growth. The next AVTX earnings date is Nov 7, 2024.

AVTX earnings history

Current Revenue
$807.0k
Current Earnings
-$36.2M
Current Profit Margin
-4,488.6%

AVTX Return on Equity

Current Company
N/A
Current Industry
22.8%
Current Market
33.7%

AVTX Return on Assets

Current Company
-51.3%
Current Industry
3.5%
AVTX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when AVTX announces earnings.

AVTX Return on Capital Employed

Current Company
-300.39%
Current Industry
21.3%
AVTX's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

AVTX vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
AVTX-$35.63M-$36.22MN/A-$46.79
CANF-$7.27M-$7.37MN/A-$3.00
SNTI-$50.74M-$56.95MN/A-$12.65
CDT-$4.77M-$5.17MN/A-$0.06
IKT-$18.36M-$18.38MN/A-$2.89
View Top Biotech Stocks

AVTX earnings dates

Next earnings date
Nov 7, 2024

Avalo Therapeutics Earnings Reports & History FAQ

What were Avalo Therapeutics's earnings last quarter?

On AVTX's earnings call on Invalid Date, Avalo Therapeutics (NASDAQ: AVTX) reported Q2 2024 earnings per share (EPS) of $4.21, up 102.99% year over year. Total AVTX earnings for the quarter were $98.46 million. In the same quarter last year, Avalo Therapeutics's earnings per share (EPS) was -$140.73.

If you're new to stock investing, here's how to buy Avalo Therapeutics stock.

When does Avalo Therapeutics report earnings?

The next AVTX earnings call is Invalid Date. Add AVTX to your watchlist to be reminded of Avalo Therapeutics's next earnings date.

What was AVTX's earnings growth in the past year?

As of Avalo Therapeutics's earnings date in Invalid Date, Avalo Therapeutics's earnings has grown year over year. AVTX earnings in the past year totalled -$36.22 million.

Is Avalo Therapeutics profitable or losing money?

As of the last Avalo Therapeutics earnings report, Avalo Therapeutics is currently losing money. Avalo Therapeutics's net profit (also called net income) for the twelve months ending Jun 30, 2024 was -$36.22 million, a 46.25% increase year over year.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.